EHC ENCOMPASS HEALTH CORP revenue, earnings and financials

For the quarter ended June 30, 2026, ENCOMPASS HEALTH CORP reported revenue of $1.60B (up 9.6% from a year earlier), net income of $154M and diluted EPS of $1.54; over the last four quarters revenue was $6.21B and net income $621M; for the fiscal year ended December 2025 revenue was $5.94B, up 10.5% on the year before.

EHC annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $5.94B, gross profit n/a, operating income n/a, net income $566M (margin 9.5%), EPS $5.54
• Fiscal year ended Dec 2024: revenue $5.37B, gross profit n/a, operating income n/a, net income $456M (margin 8.5%), EPS $4.46
• Fiscal year ended Dec 2023: revenue $4.80B, gross profit n/a, operating income n/a, net income $352M (margin 7.3%), EPS $3.47
• Fiscal year ended Dec 2022: revenue $4.35B, gross profit n/a, operating income $540M, net income $271M (margin 6.2%), EPS $2.70
• Fiscal year ended Dec 2021: revenue $4.01B, gross profit n/a, operating income $560M, net income $412M (margin 10.3%), EPS $4.11

EHC quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.60B (up 9.6% year over year), net income $154M, EPS $1.54
• Quarter ended Mar 31, 2026: revenue $1.59B (up 9.0% year over year), net income $195M, EPS $1.93
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.54B (up 9.9% year over year), net income $146M, EPS $1.43
• Quarter ended Sep 30, 2025: revenue $1.48B (up 9.4% year over year), net income $127M, EPS $1.24
• Quarter ended Jun 30, 2025: revenue $1.46B (up 12.0% year over year), net income $142M, EPS $1.39
• Quarter ended Mar 31, 2025: revenue $1.46B (up 10.6% year over year), net income $152M, EPS $1.48
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.41B (up 12.7% year over year), net income $121M, EPS $1.18
• Quarter ended Sep 30, 2024: revenue $1.35B (up 11.9% year over year), net income $108M, EPS $1.06
• Quarter ended Jun 30, 2024: revenue $1.30B (up 9.6% year over year), net income $114M, EPS $1.12
• Quarter ended Mar 31, 2024: revenue $1.32B (up 13.4% year over year), net income $113M, EPS $1.10
• Quarter ended Dec 31, 2023 (from the annual report): revenue $1.25B (up 9.6% year over year), net income $87.6M, EPS $0.86
• Quarter ended Sep 30, 2023: revenue $1.21B (up 10.8% year over year), net income $85.3M, EPS $0.84
• Quarter ended Jun 30, 2023: revenue $1.19B (up 11.7% year over year), net income $91.4M, EPS $0.90
• Quarter ended Mar 31, 2023: revenue $1.16B (up 9.5% year over year), net income $87.7M, EPS $0.87
• Quarter ended Dec 31, 2022: revenue $1.14B (up 9.1% year over year), net income $89.4M, EPS $0.89
• Quarter ended Sep 30, 2022: revenue $1.09B (up 7.8% year over year), net income $45.4M, EPS $0.45
• Quarter ended Jun 30, 2022: revenue $1.06B (up 6.1% year over year), net income $48.7M, EPS $0.49
• Quarter ended Mar 31, 2022: revenue $1.06B (up 10.4% year over year), net income $87.5M, EPS $0.87
• Quarter ended Dec 31, 2021: revenue $1.04B, net income $91.6M, EPS $0.91
• Quarter ended Sep 30, 2021: revenue $1.01B, net income $100M, EPS $1.00

EHC cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow n/a, share buybacks $158M, dividends $0.72 per share
• Fiscal year ended Dec 2024: operating cash flow n/a, share buybacks $31.1M, dividends $0.64 per share
• Fiscal year ended Dec 2023: operating cash flow n/a, share buybacks $0, dividends $0.60 per share
• Fiscal year ended Dec 2022: operating cash flow $706M, share buybacks $0, dividends $0.86 per share
• Fiscal year ended Dec 2021: operating cash flow $716M, share buybacks $0, dividends $1.12 per share

EHC balance sheet

• Jun 30, 2026: cash $108M, total assets $7.46B, total liabilities $4.00B, shareholders' equity $2.60B
• Mar 31, 2026: cash $111M, total assets $7.31B, total liabilities $3.95B, shareholders' equity $2.52B
• Dec 31, 2025: cash $72.2M, total assets $7.09B, total liabilities $3.81B, shareholders' equity $2.44B
• Sep 30, 2025: cash $48.7M, total assets $6.87B, total liabilities $3.68B, shareholders' equity $2.37B
• Jun 30, 2025: cash $99.1M, total assets $6.79B, total liabilities $3.70B, shareholders' equity $2.28B
• Mar 31, 2025: cash $95.8M, total assets $6.64B, total liabilities $3.70B, shareholders' equity $2.16B
• Dec 31, 2024: cash $85.4M, total assets $6.53B, total liabilities $3.69B, shareholders' equity $2.07B
• Sep 30, 2024: cash $148M, total assets $6.46B, total liabilities $3.73B, shareholders' equity $1.96B

What is EHC's revenue?

ENCOMPASS HEALTH CORP reported $6.21B of revenue over its last four quarters, through June 30, 2026.

Is EHC profitable?

Yes. ENCOMPASS HEALTH CORP earned $621M over the last four quarters.

What is EHC's EPS?

Diluted earnings per share over the last four quarters were $6.14; $1.54 in the latest quarter.

Does EHC pay a dividend?

ENCOMPASS HEALTH CORP paid $0.72 per share in dividends in the fiscal year ended December 2025.

EHC ownership and insider trades · All stocks